14 September 2022
Grafenia plc
("Grafenia" or the "Company")
Result of Annual General Meeting
Grafenia (AIM: GRA) announces that, at its annual general meeting held earlier today, the following resolutions were duly passed on a show of hands with the table below summarising the proxy votes:
| RESOLUTIONS | NO OF VOTES FOR | % OF VOTES CAST (EXCLUDING VOTES WITHELD) | NO OF VOTES AGAINST | % OF VOTES CAST (EXCLUDING VOTES WITHELD) | TOTAL VOTES CAST (EXCLUDING VOTES WITHHELD) | NO OF VOTES WITHHELD |
| 1) To receive the Report and Accounts of the Company for the year to 31 March 2022 | 46,361,494 | 99.96% | 19,988 | 0.04% | 46,381,482 | 26,784 |
| 2) To re-elect Jan Hendrik-Mohr as a director of the Company | 46,358,266 | 99.89% | 50,000 | 0.11% | 46,408,266 | 0 |
| 3) To re-elect Conrad Christian Bona as a director of the Company | 46,358,266 | 99.89% | 50,000 | 0.11% | 46,408,266 | 0 |
| 4) To re-appoint RSM UK Audit LLP as auditors of the Company | 46,408,266 | 100.00% | 0 | 0.00% | 46,408,266 | 0 |
| 5) To authorise the directors to replace the existing authority to allot shares in the Company in connection with s 551 of the Companies Act 2006 | 46,358,266 | 99.89% | 50,000 | 0.11% | 46,408,266 | 0 |
| 6) To authorise the directors to allot Relevant Securities as if s 561 of the Companies Act 2006 did not apply | 45,589,633 | 98.24% | 818,613 | 1.76% | 46,408,266 | 0 |
| 7) To authorise the directors to make market purchases of ordinary shares in the Company | 46,408,266 | 100.00% | 0 | 0.00% | 46,408,266 | 0 |
Votes which have been cast at the discretion of the Chairman have been counted as votes for the resolutions. Votes Withheld are not votes in law and do not count in the number of votes counted for or against a resolution.
For further information:
| Grafenia plc |
|
|
| Gavin Cockerill (Acting CEO) | 07968 510 662 | |
| | | |
| Allenby Capital Limited (Nominated Adviser and broker) | 0203 328 5656 | |
| David Hart / Piers Shimwell | | |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.